BT
Insider selling
Brian Taylor Slingsby sold $3M of Mineralys Therapeutics, Inc. (MLYS) stock
Brian Taylor Slingsby, Dir of Mineralys Therapeutics, Inc. (MLYS), sold 104,320 shares of MLYS stock worth $3M, per an SEC Form 4 filed Sep 25, 2026.
It was an open-market sale.
The trade happened on Sep 22, 2026, 3 days before it was made public.
MLYS has moved -8.5% since the trade date, from $29.40 to $26.89 (Sep 23, 2026 close).
- Traded
- Sep 22, 2026
- Disclosed
- Sep 25, 2026
- Filing delay
- 3 days
- Price since
- -8.5%
- Role
- Dir
- Source
- SEC Form 4
More MLYS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.